Answers are grounded in this paper and cite their sources.
Traditional Chinese medicine (TCM), characterized by multi-component, multi-target, and systemic therapeutic mechanisms, provides unique advantages in managing complex diseases. However, the inherent complexity of TCM formulations, including nonlinear component interactions, elusive compatibility principles, and a lack of quantitative biomarkers, has hindered the systematic elucidation of their efficacy mechanisms and clinical translation. Artificial intelligence (AI) technologies, including machine learning and deep learning, combined with network pharmacology approaches, have emerged as transformative tools to systematically characterize and model TCM’s complexity. Given that TCM and AI share a foundational emphasis on systemic interactions rather than isolated components, AI approaches can facilitate high-throughput prediction of bioactive components, rational design of synergistic formulas, and dynamic modeling of pharmacological effects. Recent interdisciplinary studies have harnessed AI to address TCM challenges including predicting bio-active constituents, optimizing herbal compatibility, and standardizing diagnostic parameters. Whereas prior reviews focused on AI applications in TCM data mining and drug development, this work comprehensively integrates active component prediction, compatibility mechanisms, and pharmacological effect modeling, and additionally discusses emerging applications of large-scale AI models in modern TCM research.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: